Nephrological treatment of severe heart failure

被引：0
|
作者：
Schwenger, V. [1 ]
Remppis, B. A. [2 ]
机构：
[1] Klinikum Stuttgart, Transplantat Zentrum Stuttgart, Klin Nieren Hochdruck & Autoimmunerkrankungen, Katharinenhosp Stuttgart, Haus 1,Kriegsbergstr 60, D-70174 Stuttgart, Germany
[2] Herz & Gefasszentrum, Klin Kardiol, Bad Bevensen, Germany
来源：
NEPHROLOGE | 2018年 / 13卷 / 02期
关键词：
Cardio-renal syndrome; Congestive heart failure; Renal insufficiency; Ultrafiltration; Interdisciplinary therapy;
D O I：
10.1007/s11560-017-0223-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic heart failure is not only one of the fastest growing morbidities in western countries but also one of the commonest reasons for hospitalization. Up to 50-60% of heart failure patients suffer from renal failure, which is often the reason for hospitalization. In patients with cardio-renal syndrome renal failure is one of the strongest predictors for mortality. Due to the close pathophysiological and prognostic interactions between these two organs, patients with cardio-renal syndrome should receive interdisciplinary, patient and symptom-oriented treatment in collaboration with cardiologists and nephrologists.
引用
收藏
页码：104 / 110
页数：7
相关论文
共 50 条
  • [31] Clinical analysis of medical treatment of elderly patients with severe heart failure
    Qian, Yue
    Shi, Hanping
    Li, Bin
    [J]. MINERVA PEDIATRICS, 2024, 76 (01): : 128 - 130
  • [32] COMBINATION OF FUROSEMIDE AND METOLAZONE IN THE TREATMENT OF SEVERE CONGESTIVE-HEART-FAILURE
    GROSSKOPF, I
    RABINOVITZ, M
    ROSENFELD, JB
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1986, 22 (11): : 787 - 790
  • [33] MOLSIDOMINE IN THE TREATMENT OF ISCHEMIA IN MODERATE AND SEVERE CONGESTIVE-HEART-FAILURE
    KOTHE, K
    FORSTER, A
    AURISCH, R
    [J]. PERFUSION, 1994, 7 (09): : 303 - 307
  • [34] Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure
    Sheppard, R
    Panyon, J
    Pohwani, AL
    Kapoor, A
    Macgowan, G
    Mcnamara, D
    Mathier, M
    Johnston, JR
    Murali, S
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : 380 - 383
  • [35] COMPARATIVE EFFECTS OF INOTROPIC AND VASODILATOR TREATMENT OF SEVERE HEART-FAILURE
    MIKULIC, E
    COHN, JN
    [J]. CIRCULATION, 1974, 50 (04) : 156 - 156
  • [36] Severe symptomatic heart failure in SHR is improved by ACE inhibitor treatment
    Itter, G
    Wiemer, G
    Juretschke, P
    Schölkens, BA
    Linz, W
    Roussel, HM
    [J]. HYPERTENSION, 1999, 34 (04) : 702 - 702
  • [37] The Role of Surgical Treatment of Severe Functional Mitral Regurgitation in Heart Failure
    Fattouch, Khalil
    Guccione, Francesco
    [J]. CARDIOLOGY CLINICS, 2021, 39 (02) : 185 - 188
  • [38] Peculiarity of severe heart failure in patients receiving antitumor treatment.
    Gendlin, G. Gennady
    Emelina, E.
    Kulieva, I.
    Nikitin, I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 43 - 44
  • [39] Vasopressin in the treatment of Milrinone-induced hypotension in severe heart failure
    Gold, J
    Cullinane, S
    Chen, J
    Seo, S
    Oz, MC
    Oliver, JA
    Landry, DW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (04): : 506 - 508
  • [40] THE ROLE OF VASODILATOR THERAPY IN THE TREATMENT OF SEVERE CHRONIC HEART-FAILURE
    PACKER, M
    [J]. DRUGS, 1986, 32 : 13 - 26
12345